Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.23.2 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.23.2 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.23.2 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.23.2 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.23.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.104 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.104 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.104 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.104 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.104 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.104 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.104 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.104 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.198EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.198ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.198ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.198EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.198EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.198ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.198ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-19663.3China
EG.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
EG.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAFEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XAFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAFECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XAFECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAFEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAFEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAFENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAFENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BC.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-11626.3Germany
BC.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BC.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
BC.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BC.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
BC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
P.1.17.1 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.17.1 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.17.1 (Gamma)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
P.1.17.1 (Gamma)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used